DE60027575T2 - Verwendung von Spinosad oder einer Zusammensetzung enthaltend spinosad - Google Patents
Verwendung von Spinosad oder einer Zusammensetzung enthaltend spinosad Download PDFInfo
- Publication number
- DE60027575T2 DE60027575T2 DE60027575T DE60027575T DE60027575T2 DE 60027575 T2 DE60027575 T2 DE 60027575T2 DE 60027575 T DE60027575 T DE 60027575T DE 60027575 T DE60027575 T DE 60027575T DE 60027575 T2 DE60027575 T2 DE 60027575T2
- Authority
- DE
- Germany
- Prior art keywords
- spinosad
- dose
- fleas
- dogs
- spinosyn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 19
- JFLRKDZMHNBDQS-UCQUSYKYSA-N CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C(=C[C@H]3[C@@H]2CC(=O)O1)C)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C.CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C=C[C@H]3C2CC(=O)O1)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C Chemical compound CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C(=C[C@H]3[C@@H]2CC(=O)O1)C)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C.CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C=C[C@H]3C2CC(=O)O1)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C JFLRKDZMHNBDQS-UCQUSYKYSA-N 0.000 title claims description 40
- 239000005930 Spinosad Substances 0.000 title claims description 40
- 229940014213 spinosad Drugs 0.000 title claims description 40
- 206010061217 Infestation Diseases 0.000 claims abstract description 20
- 244000078703 ectoparasite Species 0.000 claims abstract description 20
- 238000009472 formulation Methods 0.000 claims abstract description 18
- 238000011282 treatment Methods 0.000 claims description 34
- 241000282326 Felis catus Species 0.000 claims description 28
- 239000003826 tablet Substances 0.000 claims description 13
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 4
- 229940126601 medicinal product Drugs 0.000 claims 1
- 229930185156 spinosyn Natural products 0.000 abstract description 44
- 241001465754 Metazoa Species 0.000 abstract description 21
- 150000003839 salts Chemical class 0.000 abstract description 14
- 238000000034 method Methods 0.000 abstract description 8
- 230000002035 prolonged effect Effects 0.000 abstract description 4
- 239000006186 oral dosage form Substances 0.000 abstract 1
- 241000282472 Canis lupus familiaris Species 0.000 description 51
- 241000258242 Siphonaptera Species 0.000 description 27
- 241000238876 Acari Species 0.000 description 16
- SRJQTHAZUNRMPR-UHFFFAOYSA-N spinosyn A Natural products CC1C(=O)C2=CC3C4CC(OC5C(C(OC)C(OC)C(C)O5)OC)CC4C=CC3C2CC(=O)OC(CC)CCCC1OC1CCC(N(C)C)C(C)O1 SRJQTHAZUNRMPR-UHFFFAOYSA-N 0.000 description 10
- 150000001875 compounds Chemical class 0.000 description 9
- 241000258924 Ctenocephalides felis Species 0.000 description 8
- 241000607479 Yersinia pestis Species 0.000 description 8
- 238000000855 fermentation Methods 0.000 description 8
- 230000004151 fermentation Effects 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 230000009467 reduction Effects 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- SRJQTHAZUNRMPR-UYQKXTDMSA-N spinosyn A Chemical compound O([C@H]1CCC[C@@H](OC(=O)C[C@H]2[C@@H]3C=C[C@@H]4C[C@H](C[C@H]4[C@@H]3C=C2C(=O)[C@@H]1C)O[C@H]1[C@@H]([C@H](OC)[C@@H](OC)[C@H](C)O1)OC)CC)[C@H]1CC[C@H](N(C)C)[C@@H](C)O1 SRJQTHAZUNRMPR-UYQKXTDMSA-N 0.000 description 7
- 241000255925 Diptera Species 0.000 description 6
- 230000037396 body weight Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000007903 gelatin capsule Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 241000238631 Hexapoda Species 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- VEMKTZHHVJILDY-UXHICEINSA-N bioresmethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-UXHICEINSA-N 0.000 description 5
- -1 organophosphates Chemical class 0.000 description 5
- 244000045947 parasite Species 0.000 description 5
- 241000490513 Ctenocephalides canis Species 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000012669 liquid formulation Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 241001674048 Phthiraptera Species 0.000 description 3
- 244000300264 Spinacia oleracea Species 0.000 description 3
- VXSIXFKKSNGRRO-MXOVTSAMSA-N [(1s)-2-methyl-4-oxo-3-[(2z)-penta-2,4-dienyl]cyclopent-2-en-1-yl] (1r,3r)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate;[(1s)-2-methyl-4-oxo-3-[(2z)-penta-2,4-dienyl]cyclopent-2-en-1-yl] (1r,3r)-3-[(e)-3-methoxy-2-methyl-3-oxoprop-1-enyl Chemical class CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)O[C@@H]1C(C)=C(C\C=C/C=C)C(=O)C1.CC1(C)[C@H](/C=C(\C)C(=O)OC)[C@H]1C(=O)O[C@@H]1C(C)=C(C\C=C/C=C)C(=O)C1 VXSIXFKKSNGRRO-MXOVTSAMSA-N 0.000 description 3
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 239000002949 juvenile hormone Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- HYJYGLGUBUDSLJ-UHFFFAOYSA-N pyrethrin Natural products CCC(=O)OC1CC(=C)C2CC3OC3(C)C2C2OC(=O)C(=C)C12 HYJYGLGUBUDSLJ-UHFFFAOYSA-N 0.000 description 3
- 229940070846 pyrethrins Drugs 0.000 description 3
- 239000002728 pyrethroid Substances 0.000 description 3
- 230000009885 systemic effect Effects 0.000 description 3
- 241000283086 Equidae Species 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- CEAGUSGLAUVBEQ-UHFFFAOYSA-N Forosamine Natural products CC1CC(N(C)C)CC(O)O1 CEAGUSGLAUVBEQ-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 2
- 241000257226 Muscidae Species 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000007910 chewable tablet Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- SZGAAHDUAFVZSS-SFYZADRCSA-N forosamine Chemical compound C[C@@H](O)[C@@H](N(C)C)CCC=O SZGAAHDUAFVZSS-SFYZADRCSA-N 0.000 description 2
- 239000002917 insecticide Substances 0.000 description 2
- 229930014550 juvenile hormone Natural products 0.000 description 2
- 150000003633 juvenile hormone derivatives Chemical class 0.000 description 2
- 231100000518 lethal Toxicity 0.000 description 2
- 230000001665 lethal effect Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000003120 macrolide antibiotic agent Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 150000004045 organic chlorine compounds Chemical class 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000005022 packaging material Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- RDECBWLKMPEKPM-UHFFFAOYSA-N spinosyn D Natural products CC1C(=O)C2=CC3C4CC(OC5C(C(OC)C(OC)C(C)O5)OC)CC4C(C)=CC3C2CC(=O)OC(CC)CCCC1OC1CCC(N(C)C)C(C)O1 RDECBWLKMPEKPM-UHFFFAOYSA-N 0.000 description 2
- RDECBWLKMPEKPM-PSCJHHPTSA-N spinosyn D Chemical compound O([C@H]1CCC[C@@H](OC(=O)C[C@H]2[C@@H]3C=C(C)[C@@H]4C[C@H](C[C@H]4[C@@H]3C=C2C(=O)[C@@H]1C)O[C@H]1[C@@H]([C@H](OC)[C@@H](OC)[C@H](C)O1)OC)CC)[C@H]1CC[C@H](N(C)C)[C@@H](C)O1 RDECBWLKMPEKPM-PSCJHHPTSA-N 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 239000007916 tablet composition Substances 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- 239000005660 Abamectin Substances 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
- 208000003732 Cat-scratch disease Diseases 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000242722 Cestoda Species 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000474140 Ctenocephalides felis felis Species 0.000 description 1
- 241000256113 Culicidae Species 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000003917 Dirofilariasis Diseases 0.000 description 1
- 241000282324 Felis Species 0.000 description 1
- PNKUSGQVOMIXLU-UHFFFAOYSA-N Formamidine Chemical class NC=N PNKUSGQVOMIXLU-UHFFFAOYSA-N 0.000 description 1
- 241000258937 Hemiptera Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 241000255777 Lepidoptera Species 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000305186 Persectania ewingii Species 0.000 description 1
- 241000257186 Phormia regina Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241001481696 Rhipicephalus sanguineus Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 238000005056 compaction Methods 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000001984 ectoparasiticidal effect Effects 0.000 description 1
- 239000013057 ectoparasiticide Substances 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 244000079386 endoparasite Species 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 150000002337 glycosamines Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229930191400 juvenile hormones Natural products 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229940041033 macrolides Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- FXWHFKOXMBTCMP-WMEDONTMSA-N milbemycin Natural products COC1C2OCC3=C/C=C/C(C)CC(=CCC4CC(CC5(O4)OC(C)C(C)C(OC(=O)C(C)CC(C)C)C5O)OC(=O)C(C=C1C)C23O)C FXWHFKOXMBTCMP-WMEDONTMSA-N 0.000 description 1
- ZLBGSRMUSVULIE-GSMJGMFJSA-N milbemycin A3 Chemical class O1[C@H](C)[C@@H](C)CC[C@@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 ZLBGSRMUSVULIE-GSMJGMFJSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000003129 miticidal effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000000668 oral spray Substances 0.000 description 1
- 239000007935 oral tablet Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 235000017807 phytochemicals Nutrition 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 150000003217 pyrazoles Chemical class 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 230000012865 response to insecticide Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- WSWCOQWTEOXDQX-MQQKCMAXSA-N sorbic acid group Chemical group C(\C=C\C=C\C)(=O)O WSWCOQWTEOXDQX-MQQKCMAXSA-N 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000440 toxicity profile Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 231100000925 very toxic Toxicity 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
- A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
- A01N43/22—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom rings with more than six members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Dentistry (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Environmental Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14861899P | 1999-08-12 | 1999-08-12 | |
| US148618P | 1999-08-12 | ||
| PCT/US2000/019557 WO2001011963A1 (en) | 1999-08-12 | 2000-08-02 | Oral treatment of companion animals with ectoparasiticidal spinosyns |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60027575D1 DE60027575D1 (de) | 2006-06-01 |
| DE60027575T2 true DE60027575T2 (de) | 2007-02-15 |
Family
ID=22526570
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60027575T Expired - Lifetime DE60027575T2 (de) | 1999-08-12 | 2000-08-02 | Verwendung von Spinosad oder einer Zusammensetzung enthaltend spinosad |
| DE201112100022 Pending DE122011100022I1 (de) | 1999-08-12 | 2000-08-02 | Verwendung von Spinosad oder einer Zusammensetzungenthaltend spinosad. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE201112100022 Pending DE122011100022I1 (de) | 1999-08-12 | 2000-08-02 | Verwendung von Spinosad oder einer Zusammensetzungenthaltend spinosad. |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US6664237B1 (enExample) |
| EP (1) | EP1207756B1 (enExample) |
| JP (2) | JP5046455B2 (enExample) |
| KR (1) | KR100706146B1 (enExample) |
| AT (1) | ATE324039T1 (enExample) |
| AU (1) | AU775488B2 (enExample) |
| BE (1) | BE2011C013I2 (enExample) |
| BR (1) | BR0013116B1 (enExample) |
| CA (1) | CA2379329C (enExample) |
| CO (1) | CO5410187A1 (enExample) |
| CY (1) | CY1105000T1 (enExample) |
| DE (2) | DE60027575T2 (enExample) |
| DK (1) | DK1207756T3 (enExample) |
| ES (1) | ES2261229T3 (enExample) |
| FR (1) | FR11C0017I2 (enExample) |
| HU (1) | HUP0202825A2 (enExample) |
| IL (2) | IL147828A0 (enExample) |
| MX (1) | MXPA02001505A (enExample) |
| MY (1) | MY125485A (enExample) |
| NO (1) | NO20020686L (enExample) |
| NZ (1) | NZ516790A (enExample) |
| PT (1) | PT1207756E (enExample) |
| TW (1) | TWI244373B (enExample) |
| WO (1) | WO2001011963A1 (enExample) |
| ZA (1) | ZA200200565B (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6933318B1 (en) | 1999-08-12 | 2005-08-23 | Eli Lilly And Company | Topical organic ectoparasiticidal formulations |
| AUPQ441699A0 (en) | 1999-12-02 | 2000-01-06 | Eli Lilly And Company | Pour-on formulations |
| DE10135550A1 (de) * | 2001-07-20 | 2003-01-30 | Bayer Cropscience Ag | Verfahren zum Herstellen von neuen Spinosyn-Derivaten |
| EP2347654B1 (en) | 2001-09-17 | 2019-02-27 | Elanco US Inc. | Formulation for controlling lice or ticks in catlle |
| EP1682118B1 (en) * | 2003-11-04 | 2008-10-22 | Intervet International BV | Ectoparasiticidal formulations of spinosyns and azole pesticides |
| BRPI0508140B1 (pt) | 2004-03-05 | 2015-03-17 | Nissan Chemical Ind Ltd | Composto benzamida substituída por isoxazolina da fórmula (1); da fórmula (2) substituído por 3,5-bis (aril substituído); da fórmula (4) substituída por alquinibenzeno ou um sal do mesmo; "pesticida, agroquímico, inseticida, parasiticida contendo como ingrediente ativo um ou mais composto benzamida substituída por isoxazolina e sal do mesmo" |
| SG159395A1 (en) * | 2004-04-29 | 2010-03-30 | Lilly Co Eli | Use of spinosyns for wound healing |
| AU2004319804B2 (en) * | 2004-04-29 | 2010-08-05 | Elanco Us Inc. | Use Of Spinosyns For Wound Healing |
| EP1890538B1 (en) | 2005-05-26 | 2015-10-28 | Eli Lilly And Company | Improved fish production |
| KR100855417B1 (ko) * | 2006-10-27 | 2008-08-29 | 일라이 릴리 앤드 캄파니 | 스피노신을 포함하는 상처 치유용 제약 조성물 |
| DK2182945T3 (en) | 2007-06-27 | 2015-11-16 | Du Pont | PROCEDURE TO COMBAT PESTS WITH ANIMALS |
| US9820977B2 (en) | 2008-10-03 | 2017-11-21 | Bayer Healthcare Llc | Systemic treatment of blood-sucking and blood-consuming parasites by oral administration of a parasiticidal agent |
| UA108200C2 (uk) * | 2009-05-08 | 2015-04-10 | Лікарські форми та способи застосування ектопаразитоцидів | |
| AU2013273709B2 (en) * | 2009-05-08 | 2015-04-23 | Eli Lilly And Company | Ectoparasiticidal methods and formulations |
| TWI510189B (zh) | 2009-06-19 | 2015-12-01 | Lilly Co Eli | 殺外寄生蟲之方法及調配物 |
| WO2010150100A1 (en) | 2009-06-24 | 2010-12-29 | Entarco Sa | The use of spinosyns and spinosyn compositions against diseases caused by protozoans, viral infections and cancer |
| BR112012018286A2 (pt) * | 2010-01-25 | 2018-06-05 | Lilly Co Eli | processo para o controle interno ou para o tratamento de larvas de berne equino |
| MX2013005126A (es) * | 2010-11-05 | 2013-06-03 | Lilly Co Eli | Metodos para inhibir las infestaciones de insectos. |
| ITMI20111945A1 (it) * | 2011-10-26 | 2013-04-27 | Zapi Ind Chimiche Spa | Formulazione in forma idonea a veicolare un quantitativo dosato di una sostanza attiva |
| CN103125501A (zh) * | 2011-11-30 | 2013-06-05 | 上海农乐生物制品股份有限公司 | 一种阿维菌素·多杀霉素水乳剂及其制备方法 |
| TW201416077A (zh) * | 2012-07-26 | 2014-05-01 | Lilly Co Eli | 單一劑量口服調配物及使用殺外寄生蟲劑賜諾殺（ｓｐｉｎｏｓａｄ）以治療貓之方法 |
| BR112015009794A2 (pt) | 2012-11-14 | 2017-07-11 | Lilly Co Eli | métodos e formulações ectoparasiticidas |
| WO2020012406A1 (en) * | 2018-07-11 | 2020-01-16 | Jubilant Generics Limited | Veterinary dosage forms |
| CN109221133A (zh) * | 2018-09-28 | 2019-01-18 | 绩溪农华生物科技有限公司 | 一种多杀菌素增效水乳剂及其制备方法 |
| WO2022192614A1 (en) * | 2021-03-11 | 2022-09-15 | In The Bowl Animal Health, Inc. | Oral canine feed and methods for controlling flea infestations in a canine |
| EP4304722A4 (en) * | 2021-03-11 | 2025-01-22 | In the Bowl Animal Health, Inc. | METHODS FOR CONTROLLING FLEA AND TICK INFESTATIONS IN A MAMMAL |
| CA3211585A1 (en) * | 2021-03-11 | 2022-09-15 | In The Bowl Animal Health, Inc. | Feed and methods for controlling tick infestations in a mammal |
| CN117915782A (zh) * | 2021-06-25 | 2024-04-19 | 碗中动物健康公司 | 猫科动物口服饲料和在猫科动物中控制蚤侵袭的方法 |
| CA3224223A1 (en) * | 2021-06-25 | 2022-12-29 | In The Bowl Animal Health, Inc. | Oral feline feed and methods for controlling flea infestations in a feline |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US576253A (en) * | 1897-02-02 | Manhole-cover | ||
| US5362634A (en) | 1989-10-30 | 1994-11-08 | Dowelanco | Process for producing A83543 compounds |
| MA21697A1 (fr) | 1988-12-19 | 1990-07-01 | Dow Agrosciences Llc | Composes de macrolides. |
| JPH0375316A (ja) * | 1989-08-18 | 1991-03-29 | Tokyo Gas Denro Kk | 熱処理炉 |
| US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
| US5539089A (en) | 1991-11-08 | 1996-07-23 | Dowelanco | A83543 aglycones and pseudoglycones |
| US5227295A (en) | 1991-11-08 | 1993-07-13 | Dowelanco | Process for isolating A83543 and its components |
| US5202242A (en) | 1991-11-08 | 1993-04-13 | Dowelanco | A83543 compounds and processes for production thereof |
| US5591606A (en) * | 1992-11-06 | 1997-01-07 | Dowelanco | Process for the production of A83543 compounds with Saccharopolyspora spinosa |
| EP0688332B1 (en) | 1993-03-12 | 1997-03-26 | Dowelanco | New a83543 compounds and process for production thereof |
| AU711185B2 (en) | 1995-06-14 | 1999-10-07 | Dow Agrosciences Llc | Synthetic modification to spinosyn compounds |
| US5695776A (en) | 1996-03-12 | 1997-12-09 | Fmc Corporation | Termite bait apparatus having grooves |
| US6001981A (en) * | 1996-06-13 | 1999-12-14 | Dow Agrosciences Llc | Synthetic modification of Spinosyn compounds |
| GB9624501D0 (en) * | 1996-11-26 | 1997-01-15 | Zeneca Ltd | Insecticial compositions and method |
| JPH11139912A (ja) * | 1997-11-06 | 1999-05-25 | Nissan Chem Ind Ltd | 安定化される農薬組成物 |
| GB2380133B (en) * | 1997-12-23 | 2003-05-07 | Syngenta Participations Ag | Use of macrolides in pest control |
| ID29130A (id) | 1998-07-02 | 2001-08-02 | Lilly Co Eli | Formulasi pengendali kutu pada manusia |
| AU4225700A (en) | 1999-04-12 | 2000-11-14 | Dow Agrosciences Llc | Aqueous dispersions of agricultural chemicals |
| CA2380643A1 (en) | 1999-08-12 | 2001-02-22 | Eli Lilly And Company | Topical organic ectoparasiticidal formulations |
| WO2001011961A1 (en) | 1999-08-12 | 2001-02-22 | Eli Lilly And Company | Control of ectoparasites using spinosyns |
| JP4666861B2 (ja) | 1999-09-13 | 2011-04-06 | ダウ・アグロサイエンス・エル・エル・シー | 有害生物防除性マクロライド |
| AUPQ441699A0 (en) | 1999-12-02 | 2000-01-06 | Eli Lilly And Company | Pour-on formulations |
-
2000
- 2000-08-02 MX MXPA02001505A patent/MXPA02001505A/es active IP Right Grant
- 2000-08-02 EP EP00955247A patent/EP1207756B1/en not_active Expired - Lifetime
- 2000-08-02 IL IL14782800A patent/IL147828A0/xx active IP Right Grant
- 2000-08-02 ES ES00955247T patent/ES2261229T3/es not_active Expired - Lifetime
- 2000-08-02 DK DK00955247T patent/DK1207756T3/da active
- 2000-08-02 WO PCT/US2000/019557 patent/WO2001011963A1/en not_active Ceased
- 2000-08-02 US US10/049,345 patent/US6664237B1/en not_active Expired - Lifetime
- 2000-08-02 AT AT00955247T patent/ATE324039T1/de active
- 2000-08-02 AU AU67476/00A patent/AU775488B2/en not_active Expired
- 2000-08-02 PT PT00955247T patent/PT1207756E/pt unknown
- 2000-08-02 DE DE60027575T patent/DE60027575T2/de not_active Expired - Lifetime
- 2000-08-02 KR KR1020027001773A patent/KR100706146B1/ko not_active Expired - Fee Related
- 2000-08-02 CA CA002379329A patent/CA2379329C/en not_active Expired - Lifetime
- 2000-08-02 BR BRPI0013116-4A patent/BR0013116B1/pt not_active IP Right Cessation
- 2000-08-02 DE DE201112100022 patent/DE122011100022I1/de active Pending
- 2000-08-02 NZ NZ516790A patent/NZ516790A/xx not_active IP Right Cessation
- 2000-08-02 JP JP2001516326A patent/JP5046455B2/ja not_active Expired - Lifetime
- 2000-08-02 HU HU0202825A patent/HUP0202825A2/hu unknown
- 2000-08-09 CO CO00059545A patent/CO5410187A1/es not_active Application Discontinuation
- 2000-08-11 TW TW089116161A patent/TWI244373B/zh not_active IP Right Cessation
- 2000-08-11 MY MYPI20003662A patent/MY125485A/en unknown
-
2002
- 2002-01-22 ZA ZA200200565A patent/ZA200200565B/en unknown
- 2002-01-24 IL IL147828A patent/IL147828A/en unknown
- 2002-02-11 NO NO20020686A patent/NO20020686L/no not_active Application Discontinuation
-
2006
- 2006-06-29 CY CY20061100888T patent/CY1105000T1/el unknown
-
2011
- 2011-05-24 FR FR11C0017C patent/FR11C0017I2/fr active Active
- 2011-05-24 BE BE2011C013C patent/BE2011C013I2/fr unknown
- 2011-09-29 JP JP2011214050A patent/JP5427217B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60027575T2 (de) | Verwendung von Spinosad oder einer Zusammensetzung enthaltend spinosad | |
| Pfister et al. | Systemically and cutaneously distributed ectoparasiticides: a review of the efficacy against ticks and fleas on dogs | |
| DE60310377T2 (de) | Lang wirksame, parasiten-abtötende zubereitung enthaltend eine salicylanilid verbindung, eine polymere verbindung und mindestens eine weitere parasiten-abtötende verbindung | |
| DE69126776T2 (de) | Parasitizide zusammensetzung und verfahren zu ihrer herstellung und ihre verwendung | |
| DE69823865T2 (de) | Verfahren zur erhöhung der antimikrobiellen eigenschaften von antibakteriellen antibiotika | |
| KR20040045440A (ko) | 농약 배합물 | |
| EP1241943B1 (de) | Verwendung von polysiloxanen mit quartären aminogruppen als formulierungshilfsmittel und mittel enthaltend dieselben | |
| AT506843B1 (de) | Direkt auf die haut aufzubringende lösung zur parasitenbekämpfung bei rindern und schafen | |
| EP2725899B1 (de) | Mittel zur bekämpfung von parasiten an tieren | |
| EP0616494B1 (de) | 1- n-(halo-3-pyridylmethyl)]-n-methylamino-1-alkylamino-2-nitroethylen-derivate zur bekämpfung von flöhen bei haustieren | |
| DE19780441B3 (de) | Anti-Floh- und -Zecken-Halsband auf der Grundlage von N-Phenylpyrazol für Katzen und Hunde | |
| DE60008226T2 (de) | Verfahren zur verwendung von emamectin zur behandlung von fisch-parasiten | |
| DE60017465T2 (de) | Kombination aus fluazuron und ivermectin gegen parasiten | |
| WO2001011962A1 (en) | Topical treatment for insect pests in companion animals | |
| US20030161854A1 (en) | Synergistic formulations | |
| DE69518608T2 (de) | Dauerhafte Kontrolle von Parasiten mittels langwirkender Shampoo-Formulierungen | |
| DE68910220T2 (de) | Veterinäre Zusammensetzungen zur Verwendung gegen Endoparasiten und Verfahren zu ihrer Herstellung. | |
| Singh et al. | Chemotherapeutics for control and treatment of ectoparasites in companion animals | |
| US20230413818A1 (en) | Feed and methods for controlling tick infestations in a mammal | |
| DE2754701A1 (de) | Verfahren zur bekaempfung der entwicklung von fliegen im mist von warmbluetern | |
| AU2001239017B2 (en) | Synergistic formulations | |
| DE2458464C2 (enExample) | ||
| DE102008006862A1 (de) | Wirkstoff in homöopathischer Verdünnung oder in seiner natürlichen Ursprungsverbindung zur wirksamen Prophylaxe gegen Befall von Zecken und Flöhen bei Mensch und Tier |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R067 | Examining division decision granting supplementary protection certificate |
Free format text: PRODUCT NAME: SPINOSAD ODER EIN SALZ HIERVON; REGISTRATION NO/DATE: EU/2/10/115/001-010 20110211 Spc suppl protection certif: 122011100022 Filing date: 20110715 Expiry date: 20200803 Extension date: 20250802 |
|
| R069 | Supplementary protection certificate granted |
Free format text: PRODUCT NAME: SPINOSAD ODER EIN SALZ HIERVON; REGISTRATION NO/DATE: EU/2/10/115/001-010 20110211 Spc suppl protection certif: 122011100022 Filing date: 20110715 Expiry date: 20200803 Extension date: 20250802 |